Skip to main content
. 2022 Jan 1;12(1):434–458. doi: 10.7150/thno.67300

Figure 6.

Figure 6

Schematic illustration of various subcellular targeted NPs for improved PDT-driven cancer immunotherapy. (A) ER-targeting Ds-sP/TCPP-TER NPs, (B) Ce6-loaded mitochondrial-targeting NPs, (C) enzyme-driven PM-targeting PCPK NPs. Reproduced with permission 118, 87, 120. Copyright 2020, American Chemical Society; Copyright 2018, American Chemical Society; Copyright 2019, American Chemical Society.